Varicella: Efficacy of two-dose vaccination in childhood;Varizellen: Besserer schutz durch zweimalige impfung im kindesalter

Deutsches Arzteblatt

Volumn 105, Issue 33, 2008, Pages 567-572

  Wutzler, Peter ^a,d   Knuf, Markus ^b   Liese, Johannes ^c  

^a Institut für Virologie und Antivirale Therapie

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Immunization coverage; Prevention; Prophylactic vaccination; Vaccination recommendation; Varicella

Indexed keywords

CHICKENPOX VACCINE;

ANTIBODY TITER; DOSE CALCULATION; HUMAN; IMMUNITY; MASS IMMUNIZATION; REVIEW; VACCINATION;

EID: 54249091172     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2008.0567     Document Type: Review

References (25)

1. Robert Koch-Institut: Empfehlungen der Ständigen Impfkommission (STIKO) am RKI Stand Juli 2004. Epid Bull 2004; 30: 235-50.
2. Deutsche Vereinigung zur Bekämpfung der Viruskrankheiten (DVV): Varizellenimpfung im Kindersalter - Notwendigkeit einer zweiten Gabe von monovalentem Impfstoff. Kinderärztliche Praxis 2008; 19: 75-7.
3. Banz K,Wagenpfeil S, Neiss A et al.: The cost-effectiveness of routine childhood varicella vaccination in Germany. Vaccine 2003; 21: 1256-67.
4. Wagenpfeil S, Neiss A, Banz K, Wutzler P: Empirical data on the varicella situation in Germany for vaccination decisions. Clin Microbiol Infect 2004; 10: 425-30.
5. Liese JG, Grote V, Rosenfeld E, Fischer R, Belohradsky BH, Kries RV and the ESPED Varicella Study Group: The burden of varicella complications before the introduction of routine varicella vaccination in germany. Pediatr Infect Dis J 2008; 27: 119-24.
6. Robert Koch-Institut: Begründung der STIKO für eine allgemeine Varizellenimpfung. Epid Bull 2004; 49: 421-3.
7. Robert Koch-Institut: Varizellen. Epid Bull 2008; 8: 61-7.
8. Arvin A, Gershon A: Control of varicella: why is a two-dose schedule necessary? Pediatr Infect Dis J 2006; 25: 475-6.
9. Li S, Chan IS, Matthews H et al.: Inverse relationship between six week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection. Pediatr Infect Dis J 2002; 21: 337-42.
10. Michalik DE, Steinberg SP, LaRussa PS et al.: Primary vaccine failure after one dose of varicella vaccine in healthy children. J Infect Dis 2008; 197: 944-9.
11. Chaves SS, Gargiullo P, Zhang JX et al.: Loss of vaccine-induced immunity to varicella over time. N Engl J Med 2007; 356: 1121-9.
12. Bayer O, Heininger U, Heiligensetzer C, von Kries R: Metaanalysis of vaccine effectiveness in varicella outbreaks. Vaccine 2007; 25: 6655-60.
13. Galil K, Fair E, Mountcastle N, Britz P, Seward J: Younger age at vaccination may increase risk of varicella vaccine failure. J Infect Dis 2002; 186: 102-5.
14. Kuter B, Schodel F: Second varicella vaccine dose. Pediatr Infect Dis J 2007; 26: 193-4.
15. Kuter B, Matthews H, Shinefield H et al.: Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J 2004; 23: 132-7.
16. Lopez A: Varicella outbreak involving two dose vaccine recipients - Arkansas: CDC 2007; www.cdc.gov/vaccines/recs/acip/downloads/mtg-slides-jun07/ 36-varicella-lopez.pdf
17. Watson B, Rothstein E, Bernstein H et al.: Safety and cellular and humoral immune responses of a booster dose of varicella vaccine 6 years after primary immunization. J Infect Dis 1995; 172: 217-9.
18. Reisinger KS, Brown ML, Xu J et al.: A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and Varivax. Pediatrics 2006; 117: 265-72.
19. Shinefield H, Black S, Digilio L et al.: Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children. Pediatr Infect Dis J 2005; 24: 665-9.
20. Knuf M, Habermehl P, Zepp F et al.: Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children. Pediatr Infect Dis J 2006; 25: 12-8.
21. Ngai AL, Staehle BO, Kuter BJ et al.: Safety and immunogenicity of one vs. two injections of Oka/Merck varicella vaccine in healthy children. Pediatr Infect Dis J. 1996; 15: 49-54.
22. Robert Koch-Institut: Aktualisierte Mitteilung der Ständigen Impfkommission (STIKO) am Robert Koch-Institut: Hinweise für Ärzte zum Aufklärungsbedarf bei Schutzimpfungen/Stand: 2007. Epid Bull 2007; 25: 209-32.
23. Marin M, Guris D, Chaves SS, Schmid S, Seward JF; Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC): Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2007; 56: 1-40.
24. Zhou F, Harpaz R, Jumaan AO, Winston CA, Shefer A: Impact of varicella vaccination on health care utilization. JAMA 2005; 294: 797-802.
25. Nguyen HQ, Jumaan AO, Seward JF: Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med 2005; 352: 450-8.